Thanks. The drug heading into Phase 3 is CNV1014802.
http://www.convergencepharma.com/index.asp?page_id=14
Others in the pipeline:
http://www.convergencepharma.com/index.asp?page_id=16
Convergence was also bought by Biogen earlier this year, so they have deep pockets behind them now.
Quote:
Originally Posted by LouLou1978
HI there,
Convergence Pharmaceuticals are preparing for phase 3 clinic trials for nav 1.7 blocker. They are in preparations for other candidates too, which I believe the next is diabetic neuropathy.
|